Breast Cancer Trials

Dimity Paul knew she carried an 80% risk of developing breast cancer since she was 21 years old, although it still came as a huge shock when she was diagnosed with breast cancer at 31. She spoke with us about her experience with the BRCA1 gene mutation, her participation on the OlympiA clinical trial and how being a part of a supportive workplace helped her through her treatment.